Use of organic nitrates and the risk of hip fracture: A population-based case-control study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 4, 2010, Pages 1924-1931

  Pouwels, Sander ^a   Lalmohamed, Arief ^a   Van Staa, Tjeerd ^a,b   Cooper, Cyrus ^b,c   Souverein, Patrick ^a   Leufkens, Hubertus G ^a   Rejnmark, Lars ^d   De Boer, Anthonius ^a   Vestergaard, Peter ^d   De Vries, Frank ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; ORGANIC NITRATE; DRUG DERIVATIVE; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE-5-MONONITRATE; NITRATE; VASODILATOR AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TREATMENT DURATION; ADOLESCENT; CASE CONTROL STUDY; EPIDEMIOLOGY; MIDDLE AGED; POPULATION; RISK;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; EPIDEMIOLOGIC METHODS; FEMALE; HIP FRACTURES; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; NITRATES; NITROGLYCERIN; ODDS RATIO; POPULATION; RISK; VASODILATOR AGENTS; YOUNG ADULT;

EID: 77951651034     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2342     Document Type: Article

References (26)

1. Elkayam U 1996 Nitrates in the treatment of congestive heart failure. Am J Cardiol 77:41C-51C (Pubitemid 126334763)
2. Armour KE, Van'T Hof RJ, Grabowski PS, Reid DM, Ralston SH 1999 Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 14:2137-2142
3. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N 1995 Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res 10:1040-1049
4. Koyama A, Otsuka E, Inoue A, Hirose S, Hagiwara H 2000 Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E2. Eur J Pharmacol 391:225-231
5. Lin IC, Smartt Jr JM, Nah HD, Ischiropoulos H, Kirschner RE 2008 Nitric oxide stimulates proliferation and differentiation of fetal calvarial osteoblasts and dural cells. Plast Reconstr Surg 121:1554-1566; discussion 1567-1569
6. Arasapam G, Scherer M, Cool JC, Foster BK, Xian CJ 2006 Roles of COX-2 and iNOS in the bony repair of the injured growth plate cartilage. J Cell Biochem 99:450-461
7. Jamal SA, Cummings SR, Hawker GA 2004 Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial. J Bone Miner Res 19:1512-1517
8. Wimalawansa SJ, Grimes JP, Wilson AC, Hoover DR 2009 Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss. J Clin Endocrinol Metab 94:3356-3364
9. Jamal SA, Browner WS, Bauer DC, Cummings SR 1998 Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures. J Bone Miner Res 13:1755-1759
10. Jamal SA, Goltzman D, Hanley DA, Papaioannou A, Prior JC, Josse RG 2009 Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20:737-744
11. Rejnmark L, Vestergaard P, Mosekilde L 2006 Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 21:1811-1817 (Pubitemid 46141238)
12. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M 1987 Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 317:799-804 (Pubitemid 17136471)
13. Wimalawansa S, Chapa T, Fang L, Yallampalli C, Simmons D, Wimalawansa S 2000 Frequency-dependent effect of nitric oxide donor nitroglycerin on bone. J Bone Miner Res 15:1119-1125 (Pubitemid 30350074)
14. Norwegian Institute of Public Health 2009 WHO International Working Group for drug statistics methodology. Norwegian Institute of Public Health. http://www.whocc.no/atcddd/
15. Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F 1995 Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 155:1801-1807
16. de Vries F, Pouwels S, Lammers JW, Leufkens HG, Bracke M, Cooper C, van Staa TP 2007 Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study. J Intern Med 261:170-177
17. de Vries F, Souverein PC, Cooper C, Leufkens HG, van Staa TP 2007 Use of β-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int 80:69-75
18. Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F, Stergachis A 1996 Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol 49:115-119
19. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773
20. Grisso JA, Capezuti E, Schwartz A 1996 Falls as risk factors for fractures. San Diego: Academic Press
21. de Vries F, de Vries C, Cooper C, Leufkens B, van Staa TP 2006 Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J Epidemiol 35:1301-1308
22. Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs Jr RW, Dequeker J, Favus M 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333: 1437-1443
23. Nabhan AF, Rabie NH 2008 Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis. Int J Gynaecol Obstet 103:213-216
24. Gregg EW, Cauley JA, Seeley DG, Ensrud KE, Bauer DC 1998 Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 129:81-88 (Pubitemid 28337248)
25. Savitz D 2003 Interpreting epidemiological evidence: strategies for study design and analysis. Oxford, UK: Oxford University Press
26. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V 2004 Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246-4253